Clinical Trial Update: A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease [Phase 3]

View source ↗

Summary

Phase 3 study of enpatoran in participants with cutaneous lupus manifestations with or without systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Systemic Lupus Erythematosus

Drugs mentioned

• Enpatoran (enpatoran)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE) | Phase 3 | Status: RECRUITING